Industry

DUBLIN–(BUSINESS WIRE)–The “Rare Disease Genetic Testing Market Size, Share & Trends Analysis Report by Disease Type (Neurological, CVDs), by Specialty (Molecular, Biochemical), by Technology (NGS, PCR-based), by End Use, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global rare disease genetic testing market size is expected to reach USD 2.52 billion … [Read more…]

OTTAWA, Ontario–(BUSINESS WIRE)–Operation Lifesaver (OL) Canada today unveiled four new #STOPTrackTragedies videos to mark the beginning of Rail Safety Week (September 19-25, 2022) and to remind Canadians that taking risks near tracks and trains could cost them a limb, or their life. Every year, 2,100 North Americans are seriously injured or killed when they engage … [Read more…]

– 12-Year Agreement Prioritizes Environmental Stewardship to Help Create Clean Energy Solutions and Advances Progress Towards Net-Zero Greenhouse Gas (GHG) Emissions Targets – Agreement Expected to Create Up To 350,000 Megawatt Hours (MWh) of Renewable Energy Credits per Year, Accounting for Approximately 20 Percent of Takeda’s Current Enterprise Scope 1 and 2 Greenhouse Gas (GHG) … [Read more…]

Customers can now benefit from specialized software designed to increase the profitability of Medicare Advantage risk contracts SAN DIEGO–(BUSINESS WIRE)–ForeSee Medical today announced it has launched The ForeSee App on Salesforce AppExchange, empowering customers to increase the profitability of Medicare Advantage risk contracts. The ForeSee App assists Salesforce Health Cloud users RAF scores and improves … [Read more…]

BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it is convening its annual digital health user conference, Management Expert Exchange in Transplantation (MEET), September 18-20 in Las Vegas, Nevada. The CareDx … [Read more…]

CHMP recommends approval of BRUKINSA for the treatment of relapsed or refractory marginal zone lymphoma If approved, BRUKINSA will be the first and only approved Bruton’s Tyrosine Kinase (BTK) inhibitor for marginal zone lymphoma in Europe CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused … [Read more…]

SOUTHLAKE, Texas–(BUSINESS WIRE)–OncoNano Medicine, Inc., a clinical-stage biotechnology company focused on the development of novel cancer interventions, today announced that Chief Medical Officer Kartik Krishnan, MD, PhD, will present at the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference at the Lotte New York Palace in New York City on Wednesday, September 28, 2022. Dr. Krishnan … [Read more…]

BOSTON–(BUSINESS WIRE)–Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that management will present at a fireside chat and participate in a panel discussion on prescription digital therapeutics at the virtual LifeSci Partners HealthTech Symposium on Tuesday, September 20, 2022. Details are as follows: Format: Presentation and Fireside Chat Time: 9:30 a.m. ET … [Read more…]

Julian Adams, Ph.D., to Retire and Remain on the Board as Planned Succession BOSTON–(BUSINESS WIRE)–Gamida Cell Ltd. (Nasdaq: GMDA), the global leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today announced that Abigail “Abbey” L. Jenkins, MS, has joined as President & CEO. Ms. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Markets for Insulin Drug and Delivery Technologies” report has been added to ResearchAndMarkets.com’s offering. The current report will provide an in-depth look at the insulin drug and delivery technologies market. This report analyzes the market trends of insulin drug and delivery technologies with data from 2021, estimates from 2022, projections of compound … [Read more…]